Skip to main content
  1. Home
    /
  2. IPO
    /
  3. Bio Medica Laboratories IPO
Bio Medica Laboratories IPO
3.42xsubscribed

Bio Medica Laboratories IPO

Hospital & Healthcare Services
listed
₹2.64LMin. investment

Bio Medica Laboratories Limited IPO Details

SectorHospital & Healthcare Services
Price range₹132 – ₹139
IPO type
SME
Lot size1000 shares
Issue size₹52Cr
Red Herring Prospectus
Read
Market cap
₹174.79CrLower than sector avg
RevenueApr 7 - Mar 8
₹38.2CrLower than sector avg
Growth rate3Y CAGR
53.42%

Bio Medica Laboratories IPO Subscription Status

Date
QIB
NII
Retail
Total
21-May-26
15.94 times (X)
0.09 times (X)
1.09 times (X)
1.07 times (X)
22-May-26
15.94X
1.16X
1.42X
1.58X
25-May-26
15.94X
4.23X
2.91X
3.42X

As on 21-May-26, 5:30 PM

Bio Medica Laboratories IPO Timeline

  1. Pre-apply
    20 May 2026
  2. Bid start
    21 May 2026
  3. Bid end
    25 May 2026
  4. Allotment
    26 May 2026
  5. Release of funds
    27 May 2026
  6. Demat transfer
    27 May 2026
  7. Listing
    29 May 2026

About Bio Medica Laboratories Limited

Bio Medica Laboratories is involved in the manufacturing of pharmaceutical formulations through parenteral injections. This includes the manufacturing of generic drugs through injection in both single and multidose types for both humans and animals. The company operates purely on a B2B contractual manufacturing base. There are two main classifications under which the company offers its products. There are 58 liquid injectable formulations and 15 dry powder injectable formulations offered by the company.
The business earns income from two major sources, including sales of manufactured goods and the sales of trading goods. Third-party manufacturing is the main source of earning for the company. In FY25, third-party manufacturing earned the company ₹33.28 crore as against the total revenue of ₹38.20 crore, whereas in the case of products, the contribution was ₹24.43 crore for liquid injection and ₹13.42 crore for dry powder injection. The company also saw growth in veterinary medicines, where revenue rose steeply from ₹0.33 crore in FY24 to ₹4.42 crore in FY25.
There are two production plants which are situated in Indore, Madhya Pradesh. The top 10 customers have contributed 76.45% of revenue from the operation ended on November 30, 2025, where the largest customer contributed 30.56%. The top ten suppliers have contributed 77.9% of total purchases, while the largest supplier has contributed 58.1% of total purchases as on November 30, 2025.

Checklist

Quality analysis
Revenue growth
Company valuation
Earnings expansion
Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Objectives of Bio Medica Laboratories Limited IPO

Set up of new facility
60.30%
The company will utilise ₹28.50 crore to setup new manufacturing facility at existing premises
General corporate purposes
25.80%
Part of the IPO proceeds will be used for general corporate purposes and issue expenses
Repayment of loan
13.70%
The company will utilise ₹6.50 crore for repayment of loan.

Compare

CompanyRevenue*3Y growthPATMarket capP/E ratioD/E ratio
This IPO₹38.2Cr53.42%₹9.79Cr₹174.79Cr13.031.02
This sector (avg.)₹810.55Cr---₹87.66Cr₹10,075.9Cr55.140.40
₹21,794Cr---₹1,472.1Cr₹1,00,081.3Cr59.860.96
₹7,028.46Cr---₹1,075.88Cr₹93,096.78Cr68.940.32
₹7,782.75Cr---₹809.39Cr₹64,284.69Cr63.430.28

*Revenue for financial year 7-8. Lower P/E and D/E ratios are generally preferred.

Bio Medica Laboratories IPO Contact Details

Company NameBio Medica Laboratories Limited

How to apply for Bio Medica Laboratories IPO?

  1. Step 1

    Log in to your Upstox account to access IPO investments. Next, select the current IPO section.

  2. Step 2

    Specify IPO details. Enter the number of lots and the price you wish to apply for.

  3. Step 3

    Enter UPI ID. After entering your UPI ID, click submit. This will place your bid with the exchange.

  4. Step 4

    Mandate Notification. Your UPI app will receive a mandate notification to block funds.

  5. Step 5

    Approve Request. Your funds will be blocked once you approve the mandate request on your UPI.

Bio Medica Laboratories Limited IPO FAQs

Investors can apply for the Bio Medica Laboratories IPO through their Demat account via the stock exchange or through their broker.
The issue size of the Bio Medica Laboratories IPO is 52 Cr.
Pre-applying for an IPO allows you to submit your application before the official subscription period begins.
The IPO shares will typically list on major stock exchanges such as the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), as specified in the IPO prospectus.
Bio Medica Laboratories IPO will be open between 2026-05-21 and 2026-05-25.
Bio Medica Laboratories IPO allotment date is 2026-05-27. For Bio Medica Laboratories IPO allotment status check, you can visit the website of the registrar of the IPO.
For Bio Medica Laboratories IPO, the IPO registrar is SKYLINE FINANCIAL SERVICES PRIVATE LIMITED. You can check Bio Medica Laboratories IPO allotment status on the website of the registrar.
The shares are proposed to be listed on the BSE and NSE.
The Bio Medica Laboratories IPO shares will typically be credited to your demat account one working day before the IPO's listing date, provided your application is successfully allotted.
The Bio Medica Laboratories IPO lot size is 1000 and minimum order quantity is 2000.
Bio Medica Laboratories IPO has set the price band for its IPO at 139 per equity share with a face value of 10.